Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
2.210
-0.230 (-9.43%)
At close: May 19, 2025, 4:00 PM
2.310
+0.100 (4.52%)
After-hours: May 19, 2025, 7:51 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $6.72 million as of May 19, 2025. Its market cap has decreased by -59.09% in one year.
Market Cap
6.72M
Enterprise Value
3.75M
1-Year Change
-59.09%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $6.72M, a decrease of -88.53%. That is a compound annual growth rate of -45.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 7.41M | -49.05% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |